• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

AZTREONAM Drug Record

  • Summary
  • Interactions
  • Claims
  • AZTREONAM chembl:CHEMBL158 Approved

    Alternate Names:

    NSC-646279
    CAYSTON
    AZTREONAM
    SO-26776
    SQ 26776
    SQ-26776
    AZACTAM
    PRIMBACTAM
    2-({[(1Z)-1-(2-AMINO-1,3-THIAZOL-4-YL) -2- {[(2S,3S)-2-METHYL-4-OXO-1-SULFOAZETIDIN-3-YL]AMINO} -2- OXOETHYLIDENE]AMINO}OXY)-2-METHYLPROPANOIC ACID
    AZTREONAMUM
    AZTRÉONAM
    (Z,)-2-((((2-AMINO-4-THIAZOLYL)(((2S,3S,)-2-METHYL-4-OXO-1-SULFO-3-AZETIDINYL)CARBAMOYL)METHYLENE)AMINO)OXY)-2-METHYLPROPIONIC ACID
    chemidplus:78110-38-0
    rxcui:1272
    drugbank:00355
    chembl:CHEMBL158
    pubchem.compound:5742832

    Drug Info:

    (0 More Sources)

    Publications:

    Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol
    Horie et al., 1987, Sex difference in responsiveness to Aztreonam of monooxygenase system in liver microsomes from rats., Biochem. Pharmacol.
  • AZTREONAM   CYP19A1

    Interaction Score: 0.61

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    3566801


    Sources:
    NCI

  • AZTREONAM   CYP2C9

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • AZTREONAM   CYP2C19

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • AZTREONAM   CYP1A2

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • AZTREONAM   CYP2D6

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • AZTREONAM   CYP3A4

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22931300


    Sources:
    DTC

  • NCI: AZTREONAM

    • Version: 14-September-2017

    Alternate Names:
    C28845 NCI drug code

    Drug Info:

    Publications:
    Horie et al., 1987, Sex difference in responsiveness to Aztreonam of monooxygenase system in liver microsomes from rats., Biochem. Pharmacol.

  • DTC: AZTREONAM

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL158 ChEMBL Drug ID

    Drug Info:

    Publications:
    Sakatis MZ et al., 2012, Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., Chem Res Toxicol

  • TTD: Aztreonam

    • Version: 2020.06.01

    Alternate Names:
    D0F2XV TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL158

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21